Corteva (NYSE:CTVA) Shares Gap Up After Analyst Upgrade

Corteva, Inc. (NYSE:CTVA – Get Free Report) shares gapped up prior to trading on Tuesday after JPMorgan Chase & Co. upgraded the stock from a neutral rating to an overweight rating. The stock had previously closed at $12.39, but opened at $13.08. JPMorgan Chase & Co. now has a $19.00 price target on the stock. Corteva shares last traded at $13.5960, with a volume of 7,991,892 shares changing hands.

A number of other equities research analysts have also recently weighed in on the company. UBS Group lifted their price objective on Corteva from $85.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, September 16th. Morgan Stanley reiterated an “overweight” rating and set a $18.00 target price on shares of Corteva in a report on Friday. Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. New Street Research set a $17.00 price objective on Corteva in a research report on Monday. Finally, Citigroup increased their price objective on Corteva from $86.00 to $91.00 and gave the company a “neutral” rating in a research note on Thursday, September 17th. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $73.95.

Read Our Latest Report on Corteva

Key Corteva News

Here are the key news stories impacting Corteva this week:

  • Positive Sentiment: JPMorgan upgraded Corteva to Overweight and set a $19 price target, arguing that the stock is undervalued after the Vylor spin-off. The target implies substantial upside from recent trading levels and was the primary catalyst behind the rally. JPMorgan Upgrades Corteva to Overweight
  • Positive Sentiment: Bank of America maintained a Buy rating and an $18 price target. The firm cited Corteva’s new product launches, innovation and expectations for tighter agricultural markets in 2027, which could help offset pressure on older products. Corteva remains a buy, BofA says
  • Positive Sentiment: The post-spin-off structure may improve investor focus. Corteva is now a more concentrated crop-protection company, while the separation of Vylor could make the businesses easier to value independently and allow management to emphasize operational improvement and product innovation. Corteva rallies after analyst upgrade
  • Neutral Sentiment: Corteva announced that it will release third-quarter 2026 results after the market close on November 11, followed by a webcast on November 12. The upcoming report may provide the next major catalyst, particularly for evidence that new products are offsetting legacy-product weakness. Corteva announces third-quarter earnings date
  • Negative Sentiment: A valuation report warned that Corteva could be overvalued after its recent advance, creating a potential short-term headwind if investors take profits or the company’s earnings fail to support the higher valuation. GF Value assessment of Corteva

Institutional Trading of Corteva

Several institutional investors and hedge funds have recently added to or reduced their stakes in CTVA. Wellington Management Group LLP raised its stake in Corteva by 941.7% in the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after purchasing an additional 6,881,875 shares in the last quarter. Rakuten Investment Management Inc. acquired a new stake in Corteva during the second quarter worth about $9,132,000. Kingsview Wealth Management LLC bought a new position in Corteva in the 2nd quarter valued at about $1,093,000. Jupiter Topco LLC acquired a new position in shares of Corteva in the 2nd quarter valued at approximately $544,246,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Corteva in the 2nd quarter valued at approximately $392,447,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Performance

The stock’s fifty day moving average price is $75.82 and its two-hundred day moving average price is $79.64. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The company has a market cap of $9.27 billion, a P/E ratio of 9.20, a P/E/G ratio of 0.38 and a beta of 0.57.

Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same period last year, the firm posted $2.20 earnings per share. The firm’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 5.2%. The ex-dividend date was Tuesday, September 1st. Corteva’s dividend payout ratio is currently 47.68%.

About Corteva

(Get Free Report)

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.

Featured Articles

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.